This inventor holds 1 USPTO granted patent. Top assignee: The City University of New York. Active years: 1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981
Title: Innovator Spotlight: Virender K. Sarin
Introduction:
Virender K. Sarin, an accomplished inventor based in New York, NY, has made significant contributions to the field of biochemistry with his innovative research on cholesterol biosynthesis. His work focuses on developing in vivo inhibitors that present promising opportunities for treating cholesterol-related health issues.
Latest Patents:
Sarin holds a patent for his innovative creation titled “In vivo inhibitors of cholesterol biosynthesis.” This patent covers dialkyl esters of 5-carbo[etiocholane-3'.alpha.-7'.alpha., 12'.alpha.-trihydroxy-17'.beta.(1' methyl-4' butyl]oxy-4-hydroxy-4-methylpentyl-1-phosphonate and 5-carbohexadecyloxy-4-hydroxy-4-methylpentyl-1-phosphonate, which are shown to inhibit cholesterol biosynthesis in rat liver cells. The preparation methods of these active compounds are detailed within the patent, highlighting his innovative approach to combating cholesterol production at a cellular level.
Career Highlights:
Virender K. Sarin is associated with the Research Foundation of the City University of New York, where he continues to explore groundbreaking methodologies to enhance human health through biochemistry. His commitment and expertise have led to the development of his notable patent, indicating his dedication to advancing scientific knowledge and practical applications.
Collaborations:
In his research endeavors, Sarin has worked alongside notable colleagues such as Robert R. Engel and Barry Gotlinksy. Their collaborations reflect a rich exchange of ideas and expertise, further enriching the innovative environment at the Research Foundation of the City University of New York.
Conclusion:
Virender K. Sarin stands out as an influential inventor in the realm of cholesterol biosynthesis inhibitors. His significant patent is a testament to his innovative spirit and commitment to improving human health. With valuable collaborations with fellow researchers, Sarin continues to pave the way for future advancements in biochemistry and pharmacology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile